Back to User profile » Dr Xuening Dai
Papers published by Dr Xuening Dai:
Original Research
Canagliflozin as a Potential Preclinical Therapy for Tuberous Sclerosis Complex: Inhibition of Tsc2−/− Cell Proliferation via Cell Cycle Arrest and Mitochondrial Dysfunction
Ye J, Liu B, Wu J, Gao H, Wei Q, Su K, Zheng K, Dai X, Xu T, Wang Y, Liu S, Peng X, Gou L, Zhao Y, Xue B
Drug Design, Development and Therapy 2025, 19:10719-10733
Published Date: 4 December 2025
Original Research
General Medicine
Serum LCAT as a Gender-Neutral Biomarker for Early Osteoporosis: A Multicenter Cohort Validation Study
Wen Y, Cheng S, Gou L, Zhou W, Li Y, Wang R, Wu J, Dai X, Gao M, Wang L, Xue B, Wang Y
International Journal of General Medicine 2025, 18:4131-4145
Published Date: 31 July 2025